UROGEN PHARMA LTD's ticker is URGN and the CUSIP is M96088105. A total of 66 filers reported holding UROGEN PHARMA LTD in Q2 2022. The put-call ratio across all filers is - and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $607,165 | +85.8% | 43,338 | +37.2% | 0.00% | – |
| Q2 2023 | $326,842 | -72.9% | 31,579 | -75.8% | 0.00% | – |
| Q1 2023 | $1,206,882 | +12.9% | 130,615 | +8.4% | 0.00% | – |
| Q4 2022 | $1,068,622 | +7.0% | 120,476 | +0.3% | 0.00% | – |
| Q3 2022 | $999,000 | -1.3% | 120,072 | -2.9% | 0.00% | – |
| Q2 2022 | $1,012,000 | -9.5% | 123,607 | -3.7% | 0.00% | – |
| Q1 2022 | $1,118,000 | +185.2% | 128,317 | +211.0% | 0.00% | – |
| Q4 2021 | $392,000 | -36.2% | 41,262 | +12.9% | 0.00% | – |
| Q3 2021 | $614,000 | -55.1% | 36,543 | -59.2% | 0.00% | – |
| Q2 2021 | $1,369,000 | +110.6% | 89,635 | +169.0% | 0.00% | – |
| Q1 2021 | $650,000 | +5.5% | 33,322 | -2.5% | 0.00% | – |
| Q4 2020 | $616,000 | +146.4% | 34,186 | +163.8% | 0.00% | – |
| Q3 2020 | $250,000 | -30.0% | 12,959 | -5.2% | 0.00% | – |
| Q2 2020 | $357,000 | +56.6% | 13,665 | +7.0% | 0.00% | – |
| Q1 2020 | $228,000 | -23.2% | 12,770 | +43.5% | 0.00% | – |
| Q4 2019 | $297,000 | +33.2% | 8,899 | -5.3% | 0.00% | – |
| Q3 2019 | $223,000 | -7.5% | 9,399 | +40.2% | 0.00% | – |
| Q2 2019 | $241,000 | -66.4% | 6,704 | -65.5% | 0.00% | – |
| Q1 2019 | $717,000 | +785.2% | 19,424 | +938.2% | 0.00% | – |
| Q4 2018 | $81,000 | +62.0% | 1,871 | +77.0% | 0.00% | – |
| Q3 2018 | $50,000 | -5.7% | 1,057 | 0.0% | 0.00% | – |
| Q2 2018 | $53,000 | – | 1,057 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| GREAT POINT PARTNERS LLC | 2,620,545 | $36,713,835 | 6.69% |
| Wildcat Capital Management, LLC | 495,606 | $6,943,440 | 2.79% |
| SILVERARC CAPITAL MANAGEMENT, LLC | 508,883 | $7,129,451 | 2.16% |
| Opaleye Management Inc. | 320,000 | $4,483,200 | 1.46% |
| AlphaCentric Advisors LLC | 165,000 | $2,311,650 | 1.31% |
| Soleus Capital Management, L.P. | 372,000 | $5,211,720 | 0.48% |
| EAM Investors, LLC | 170,523 | $2,389,027 | 0.46% |
| RA Capital Management | 1,483,697 | $20,786,595 | 0.41% |
| Parkman Healthcare Partners LLC | 145,311 | $2,035,807 | 0.37% |
| MENORA MIVTACHIM HOLDINGS LTD. | 2,303,031 | $32,265,464 | 0.29% |